A single intraperitoneal (ip) inoculation of heat-killed Actinobacillus suis ATCC 15557 (AS 15557) into normal and immunosuppressed (dexamethasone-treated) mice led to remarkable nonspecific resistance to ip challenge with lethal doses of opportunistic pathogens such as Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus and Candida albicans. The duration of this enhanced protective action and the minimal effective dose, in normal mice, induced by AS 15557 were superior to those induced by other bacterial immunostimulants such as heat-killed Lavtobacillus casei YIT 9018 (LC 9018) and penicillin-treated Streptococcus pyogenes, Su (0K-432). In immunosuppressed mice, the reduced in vivo killing activity of peritoneal exudate cells (PECs) against P. aeruginosa infection was markedly augmented by ip injection of AS 15557. The degree of PEC augmentation induced by AS 15557 was higher than that induced by LC 9018 or by OK-432. The toxicity and histopathological changes associated with AS 15557 were very low, as compared with those by produced by LC 9018 and OK-432. The results suggest that AS 15557, which showed a strong resistance-enhancing capacity against opportunistic bacterial infections, may be a useful bacterial immunostimulant.
Introduction
Bacterial immunostimulants such as Mycobacterium bovis (BCG), Propionibacterium acnes (Corynebacterium parvum) and an attenuated Streptococcus pyogenes are well known to have strong antitumor and antimicrobial actions in experimental animals and patients1-9). However, it is essential to pay careful attention to side reactions in clinical applications for cancer therapy and/or infectious diseases since these bacteria are naturally pathogenic. As an example, a side reaction such as penicillin-shock due to the S. pyogenes cell preparation (OK-432) can occur easily because the attenuation of OK-432 is achieved by treatment with a high dose of penicillin G10). The author and colleagues"-") and Mutai et al. 14, 15) have reported that a heat-killed Lactobacillus casei cell preparacapsulatus and A. actinomycetemcomitans), is a gram-negative capnophilic coccobacillus belonging to the Pasteurellaceae family17). A. suis is found as a commensal agent in alimentary, respiratory and genital tracts of several normal animals such as swine, cattle and horses17- 20) There have been no reports, to date, indicating that the genus Actinobacillus cells show immunopotentiating actions against microbial infections. The objective of the present study was to determine whether or not a heat-killed A. suis cell preparation shows resistance-enhancing effects on bacterial infections in normal and immunosuppressed animals. This assay system has been described previously13). In brief, mice immunosuppressed by DM treatment (n=3) were challenged ip with P. aeruginosa (1.0 X 105 CFUs) 3 days after the ip inoculation with 0.1 mg of AS 15557, LC 9018 or OK-432. Three hours later, 2.5 ml of Hanks balanced salt solution (HBSS) containing 4 units heparin/ml was inoculated into the peritoneal cavities of DMtreated mice, and peritoneal fluid was then harvested after gently massaging the abdomen. This procedure was repeated once. As controls (at zero time), the same number of P. aeruginosa was inoculated into the peritoneal cavity of normal (DM-untreated) control mice. The peritoneal fluids were harvested immediately and centrifuged at 170 x g for 10 min. The pooled cell pellets were disrupted with 5 ml of 0.85% NH4C1 solution at room temperature for 20 min to release the phagocytosed bacteria from PECs. Each sample was serially diluted 10-fold with HBSS, and the number of CFUs was determined by plating on NAC agar plates. The PECs were counted with a hemocytometer under a microscope, and the cell populations of PECs was calculated by measns of the following formula: Killing activity (%) = Total CFUs (at zero time after 3 hr)/Total CFUs at zero time X 100. In this formula, total CFUs indicates CFUs in the supernatant fluid plus PEC CFUs.
The lethal dose (LD)50 values of immunostimulants
Normal mice in groups of 5 were each given ip, iv or sc injections, or an oral dose, of either serially 2-fold diluted AS 15557, LC 9018 or OK-432. Mortality was recorded on day 50 after the inoculation. The LD50 value was determined by the method of Reed and Muench2l) Histopathological observations Mice (n=3) were injected ip with 0.5 mg (20 mg/kg) of AS 15557, LC 9018 or OK-432. The liver and spleen were removed on the 10th day after inoculation and fixed in 10% formalin. As controls, mice (n= 3) were injected ip with saline (0.2 ml). Tissue sections of these organs were made from all fixed preparations and stained with hematoxylin and eosin solution.
Results
Comparison of protective actions of immunostimulants against infections with bacterial pathogens in normal mice
As shown in Table 1 , normal mice mainfested significantly enhanced resistance to P. aeruginosa, MRSA and C. albicans infections with all four kinds of immunostimulants (AS 15557, AA 29522, LC 9018 and OK-432) tested. Among them, the protective actions of the genus Actinobacillus (AS and AA) were comparatively stronger than those of LC 9018 and OK-432. In particular, AS 15557 exhibited the highest host resistance-enhancing capacity. Duration of protective action of immunostimulants against P. aeruginosa infection in normal mice Mice (n=10) were challenged ip with P. aeruginosa (1.8 x 10' CFUs) 3, 7, 10, 14 or 21 days after ip inoculation with or without 0.5 mg of AS 15557 (e), AA 29522 (0) or LC 9018 (A). The survival rates were recorded on day 10 after the challenge. *P <0.05, **P <0.01. Fig. 1 shows the changes in survival rates of mice (%) infected ip with P. aeruginosa at indicated intervals after ip administration of AS 15557, AA 29522 or LC 9018 (0.05 mg/mouse: 2 mg/kg). All control grouup mice died within 24 hr after the infection, while 60% of mice survived if they were challenged on the 10th day after the ip administration of AS 15557 (P <0.05) . On the other hand, significant numbers of survivor mice were noted on the 7th day with AA 29522 and on the 3rd day with LC 9018. Effective actions against P. aeruginosa infection in normal mice based on routes of immunostimulant administration Mice (n=10) were infected ip, iv or sc with P. aeruginosa on the 3rd day after the ip , iv or sc administration of AS 15557 or LC 9018 (Table 2 ) . In the case of the same routes of inoculation and infection (ip via ip, iv via iv and sc via sc), host resistance-enhancing capacities were seen in the AS 15557-administered and the LC 9018-administered groups. Howerver, with differing routes such as ip via iv, ip via sc and iv via sc, there was no significant protective effect against P. aeruginosa infection . Table 3 Minimal effective dose of immunostimulants against P. aeruginosa infection in normal mice
Mice (n=10) were inoculated ip with or without the various doses of AS 15557 and LC 9018 indicated, and then infected ip with P . aeruginosa (1.8 x 10' CFUs) 3 days after the inoculation. The survival rates were recorded on day 10 after the challenge . *p < 0 .05, * *p < 0.01. were also challenged with P. aeruginosa (%). Killing activities of PECs from these mice 3 hr after infection were determined as described in "Materials and Methods". MOs: 67.0 %, PMNs: 8.9%) or OK-432 (2 .5 x 10' cells/mouse, M q s: 64.8%, PMNs: 7.8%). Histopathological features of liver and spleen from mice injected ip with immunostimulants Histopathological findings of the liver and spleen from mice (n=3) 10 days after ip administration of AS 15557, LC 9018 or OK-432 (0 .5 mg/mous) are summarized in Table 5 . In the livers of mice inoculated with LC 9081, a large number of small and intermediate nodular infiltrations consisting of inflammatory cells, mainly monocytes together with neutrophils , were prominent in sinusoids with an irregular distruibution to lobules. The major lesions were composed of necrosis of hepatic cells , that is, severe necrotizing inflammatory lesions of the septic type . Histopathological changes in the livers of mice inoculated ip with AS 15557 or OK-432 were relatively mild as compared to those observed with LC 9018. On the other hand, the appearance of giant cells in the red pulp of the spleen was evoked by the administration of all of the immunostimulants tested , though the degree was more severe with LC 9018 and OK-432 than with AS 15557 . In contrast, none of the experimental cases showed histopathological changes in the white pulp. LD50 values of immunostimulants in normal mice In the case of ip administration, LD50 values of AS 15557, LC 9018 and OK-432 in normal female mice were 812, 561 and 141 mg/kg, respectively. LD50 values of AS 15557 , LC 9018 and OK-432 utilizing iv administration were 200, 177 and 31 mg/kg, respectively. The LD50 value of AS 15557 with oral administration was 3000 mg/kg or more. Thus , the toxicity of AS 15557 was markedly lower than that of LC 9018 or OK-432 (data not shown).
Discussion
This study was concluded to determine whether or not a single ip inoculation of heat-killed AS 15557, which is known to be present as a commensal agent in several animalsl '-20) , would lead to enhanced host defense mechanisms against opportunistic infections involving P . aeruginosa, MRSA and C. albicans. 
